
handle: 10261/76123
[ES] La presente invención proporciona, por una parte, una nueva serie de compuestos de fórmula general (I) y (II) pertenecientes a una familia amplia de derivados heterocíclicos con actividad para el tratamiento de enfermedades donde la inhibición de PDE7 es terapéutica. Preferiblemente para enfermedades inflamatorias, autoinmunes y neurodegenerativas. Por otra parte, se describen compuestos heterocíclicos, así como su procedimiento de obtención, pudiendo tener una gran aplicación como fármacos o candidatos a fármacos.
[EN] The present invention provides a novel series of compounds of general formula (I) and (II) belonging to a wide family of heterocyclic derivatives that exhibit activity for treating diseases in which PDE7 inhibition is therapeutic, preferably for inflammatory, autoimmune and neurodegenerative diseases. The invention also relates to heterocyclic compounds, and to the method for the production thereof, said compounds being widely applicable as drugs or drug candidates.
Consejo Superior de Investigaciones Científicas (España), Universidad de Santiago de Compostela, Universidad Autónoma de Madrid
A1 Solicitud de patente con informe sobre el estado de la técnica
Peer reviewed
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
